Mr. Henry Dubina reports

TELESCOPE INNOVATIONS AND AGI SDA LAUNCH TECHNOLOGY DEVELOPMENT COLLABORATION

Telescope Innovations Corp. has signed a development and collaboration agreement with AGI Group's synthesis, digitization and automation program. AGI SDA is an innovator in automated laboratory and pilot plant reactors and related control instrumentation. The partners aim to develop the next generation of automation- and artificial-intelligence-ready chemical reactor technology. This collaboration spearheads a broader effort involving six major biopharmaceutical companies focused on developing such technology, with the intent of ultimately offering an integrated commercial product.

The proposed technology would leverage Telescope's market-proven expertise in capturing high-quality and representative samples from chemical reactions and automatically transferring them to downstream instruments for analysis. This expertise is evidenced by the commercial success of its flagship product, DirectInject-LC. Telescope's technology for reliably managing reaction samples will be seamlessly integrated into the AGI reactor system, coupling automated reaction execution with real-time, hands-free analysis.

This partnership with AGI strengthens Telescope's position as the market leader for automating the sampling and analysis of chemical reactions and provides a significant commercial opportunity for both companies. For example, beyond establishing the next generation of reactor and sampling platforms, this technology could fit seamlessly into self-driving labs. SDLs combine robotic automation, real-time process analysis and artificial intelligence to autonomously execute chemistry experiments. Telescope has deployed two such systems for international biopharmaceutical clients, including Pfizer, in service of dramatically accelerating research and development across the industry.

"Global players in lab instrumentation and automation, like AGI SDA, recognize Telescope's technology advantages and are actively seeking to work with us on the future of intelligent chemistry," said Henry Dubina, chief executive officer of Telescope. "We're excited to continue pushing the envelope on tech that enables faster, lower-cost R&D for chemical process deployment, biopharmaceutical development and advanced manufacturing."

AGI SDA is part of the AGI Group, headquartered in Japan with over 1,000 employees across engineering and distribution globally. Francis Van der Eycken, chief strategy officer, AGI Group/managing director, AGI SDA, stated: "Telescope Innovations is selected as our strategic partner for the development of the sampling platform and robotics integration. AGI Group views this collaboration agreement as the start of a long-term partnership to continue developing novel and impactful solutions in this space, together with the state-of-the-art Synto platform, planned to be released mid-2027."

About Telescope Innovations Corp.

Telescope is a developer of reaction sampling technology, intelligent automation and advanced chemical manufacturing technologies. The company builds and deploys enabling technologies including reaction sampling systems for real-time analysis, flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency and data quality. The company's self-driving labs are fully autonomous, physical AI platforms that plan, execute and analyze experiments far more efficiently than traditional manual approaches. Biopharmaceutical, high-value specialty chemical and advanced material companies utilize Telescope's products and services to accelerate the development and optimization of chemical processes, thereby cutting down time and costs from lab to market.

We seek Safe Harbor.